An Osteopontin–NADPH Oxidase Signaling Cascade Promotes Pro–Matrix Metalloproteinase 9 Activation in Aortic Mesenchymal Cells

Osteopontin (OPN) is a cytokine upregulated in diabetic vascular disease. To better understand its role in vascular remodeling, we assessed how OPN controls metalloproteinase (MMP) activation in aortic adventitial myofibroblasts (AMFs) and A7r5 vascular smooth muscle cells (VSMCs). By zymography, OPN and tumor necrosis factor (TNF)-&agr; preferentially upregulate pro–matrix metalloproteinase 9 (pro-MMP9) activity. TNF-&agr; upregulated pro-MMP9 in AMFs isolated from wild-type (OPN+/+) mice, but pro-MMP9 induction was abrogated in AMFs from OPN−/− mice. OPN treatment of VSMCs enhanced pro-MMP9 activity, and TNF-&agr; induction of pro-MMP9 was inhibited by anti-OPN antibody and apocynin. Superoxide and the oxylipid product 8-isoprostaglandin F2 &agr;-isoprostane (8-IsoP) were increased by OPN treatment, and anti-OPN antibody suppressed 8-IsoP production. Like OPN and TNF-&agr;, 8-IsoP preferentially activated pro-MMP9. Superoxide, 8-IsoP, and NADPH oxidase 2 (Nox2) subunits were reduced in OPN−/− AMFs. Treatment of A7r5 VSMCs with OPN upregulated NADPH oxidase subunit accumulation. OPN structure/function studies mapped these activities to the SVVYGLR heptapeptide motif in the thrombin-liberated human OPN N-terminal domain (SLAYGLR in mouse OPN). Treatment of aortic VSMCs with SVVYGLR upregulated pro-MMP9 activity and restored TNF-&agr; activation of pro-MMP9 in OPN−/− AMFs. Injection of OPN-deficient OPN+/− mice with SVVYGLR peptide upregulated pro-MMP9 activity, 8-IsoP levels, and Nox2 protein levels in aorta and increased panmural superoxide production (dihydroethidium staining). At equivalent hyperglycemia and dyslipidemia, 8-IsoP levels and aortic pro-MMP9 were reduced with complete OPN deficiency in a model of diet-induced diabetes, achieved by comparing OPN−/−/LDLR−/− versus OPN+/−/LDLR−/− siblings. Thus, OPN provides a paracrine signal that augments vascular pro-MMP9 activity, mediated in part via superoxide generation and oxylipid formation.

[1]  Hong Wang,et al.  Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. , 2006, American journal of physiology. Renal physiology.

[2]  Su‐Li Cheng,et al.  Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. , 2005, The Journal of clinical investigation.

[3]  H. Cai.  NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. , 2005, Circulation research.

[4]  E. Schiffrin,et al.  p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Morrow.  Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[6]  Manu O. Platt,et al.  Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production From a Nox1-Based NADPH Oxidase , 2004, Circulation research.

[7]  A. Ormsby,et al.  Gene Transfer of NAD(P)H Oxidase Inhibitor to the Vascular Adventitia Attenuates Medial Smooth Muscle Hypertrophy , 2004, Circulation research.

[8]  G. Kundu,et al.  Nuclear Factor-inducing Kinase Plays a Crucial Role in Osteopontin-induced MAPK/IκBα Kinase-dependent Nuclear Factor κB-mediated Promatrix Metalloproteinase-9 Activation* , 2004, Journal of Biological Chemistry.

[9]  Y. Weng,et al.  Maturational differences in lung NF-kappaB activation and their role in tolerance to hyperoxia. , 2004, The Journal of clinical investigation.

[10]  Oscar L. Sierra,et al.  MINT, the Msx2 Interacting Nuclear Matrix Target, Enhances Runx2-dependent Activation of the Osteocalcin Fibroblast Growth Factor Response Element* , 2004, Journal of Biological Chemistry.

[11]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[12]  Y. Matsui,et al.  Role of Osteopontin in Cardiac Fibrosis and Remodeling in Angiotensin II–Induced Cardiac Hypertrophy , 2004, Hypertension.

[13]  J. Galligan,et al.  Increased O2·− Production and Upregulation of ETB Receptors by Sympathetic Neurons in DOCA-Salt Hypertensive Rats , 2004, Hypertension.

[14]  N. Fedarko,et al.  Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  C. Patterson,et al.  Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species , 2004, Circulation research.

[16]  Su‐Li Cheng,et al.  Teriparatide (Human Parathyroid Hormone (1–34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice* , 2003, Journal of Biological Chemistry.

[17]  W. Hsueh,et al.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. , 2003, The Journal of clinical investigation.

[18]  Jack L. Martin,et al.  Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries , 2003, Circulation.

[19]  M. McKee,et al.  Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. , 2002, The American journal of pathology.

[20]  A. Loewy,et al.  Osteopontin Transcription in Aortic Vascular Smooth Muscle Cells Is Controlled by Glucose-regulated Upstream Stimulatory Factor and Activator Protein-1 Activities* , 2002, The Journal of Biological Chemistry.

[21]  A. Loewy,et al.  Regulation of Osteocalcin Gene Expression by a Novel Ku Antigen Transcription Factor Complex* , 2002, The Journal of Biological Chemistry.

[22]  E. Wouters,et al.  Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways , 2002 .

[23]  F. Ohsuzu,et al.  Osteopontin Plays an Important Role in the Development of Medial Thickening and Neointimal Formation , 2002, Circulation research.

[24]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[25]  R. Leboeuf,et al.  LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[26]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[27]  A. Chiavegato,et al.  Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.

[28]  M. Noda,et al.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. , 2001, The Journal of clinical investigation.

[29]  I Lebedeva,et al.  Antisense oligonucleotides: promise and reality. , 2001, Annual review of pharmacology and toxicology.

[30]  T. Latifi,et al.  Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice* , 1998, The Journal of Biological Chemistry.

[31]  S. Schwartz,et al.  Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[32]  T. Steinbach,et al.  Changes of euchromatin/heterochromatin ratios in cell nuclei of the aortic adventitia in diabetic rats. , 1987, Artery.